The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma

Acta Oncologica

Volumn 44, Issue 8, 2005, Pages 913-917

  Björk Eriksson, Thomas ^a   Bjelkengren, Göran ^b   Glimelius, Bengt ^c,d  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEART; HUMAN; LUNG; LYMPHOMA; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SARCOMA; STATISTICAL ANALYSIS; SWEDEN; THYMOMA;

HUMANS; LYMPHOMA; MODELS, BIOLOGICAL; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SARCOMA; SWEDEN; THYMOMA;

EID: 28844507586     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860500355983     Document Type: Review

References (39)

1. Cancer Incidence in Sweden. Epidemiologiskt Centrum 2003; www.sos.se.
2. Gustavsson A, Osterman B, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma. Acta Oncol 2003;42:605-19.
3. Gustavsson A, Osterman B, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in Hodgkin's lymphoma. Acta Oncol 2003;42:589-604.
4. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-92.
5. Hejna M, Haberl I, Raderer M. Nonsurgical management of malignant thymoma. Cancer 1999;85:1871-84.
6. Whooley BP, Urschel JD, Antkowiak JG, Takita H. A 25-year thymoma treatment review. J Exp Clin Cancer Res 2000;19:3-5.
7. Batata MA, Martini N, Huvos AG, Aguilar RI, Beattie EJ, Jr. Thymomas: clinicopathologic features, therapy, and prognosis. Cancer 1974;34:389-96.
8. Maggi G, Giaccone G, Donadio M, Ciuffreda L, Dalesio O, Leria G, et al. Thymomas. A review of 169 cases, with particular reference to results of surgical treatment. Cancer 1986;58:765-76.
9. Strander H, Turesson I, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol 2003;42:516-31.
10. Möller TR, Brorsson B, Ceberg J, Frodin JE, Lindholm C, Nylen U, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 2003;42:387-410.
11. Talbäck M, Stenbeck M, Rosén M, Glimelius B. Cancer survival in Sweden. Acta Oncol 2003;42:637-59.
12. Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002;20:3484-94.
13. Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003;290:465-75.
14. Travis L. Therapy-associated secondary solid cancer. Acta Oncol 2002;41:323-33.
15. Lee YK, Cook G, Flower MA, Rowbottom C, Shahidi M, Sharma B, et al. Addition of (18)F-FDG-PET scans to radiotherapy planning of thoracic lymphoma. Radiother Oncol 2004;73:277-83.
16. Goodman KA, Toner S, Hunt M, Wu EJ, Yahalom J. Intensity-modulated radiotherapy for lymphoma involving the mediastinum. Int J Radiat Oncol Biol Phys 2005;62:198-206.
17. Schmidt-Wolf IG, Rockstroh JK, Schuller H, Hirner A, Grohe C, Muller-Hermelink HK, et al. Malignant thymoma: current status of classification and multimodality treatment. Ann Hematol 2003;82:69-76.
18. Urgesi A, Monetti U, Rossi G, Ricardi U, Casadio C. Role of radiation therapy in locally advanced thymoma. Radiother Oncol 1990;19:273-80.
19. Uematsu M, Kondo M. A proposal for treatment of invasive thymoma. Cancer 1986;58:1979-84.
20. Uematsu M, Yoshida H, Kondo M, Itami J, Hatano K, Isobe K, et al. Entire hemithorax irradiation following complete resection in patients with stage II-III invasive thymoma. Int J Radiat Oncol Biol Phys 1996;35:357-60.
21. Mornex F, Resbeut M, Richaud P, Jung GM, Mirabel X, Marchal C, et al. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Int J Radiat Oncol Biol Phys 1995;32:651-9.
22. Yorke ED, Jackson A, Rosenzweig KE, Merrick SA, Gabrys D, Venkatraman ES, et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 2002;54:329-39.
23. Applefeld MM, Slawson RG, Hall-Craigs M, Green DC, Singleton RT, Wiernik PH. Delayed pericardial disease after radiotherapy. Am J Cardiol 1981;47:210-3.
24. Veeragandham RS, Goldin MD. Surgical management of radiation-induced heart disease. Ann Thorac Surg 1998;65:1014-9.
25. Knight CJ, Sutton GC. Complete heart block and severe tricuspid regurgitation after radiotherapy. Case report and review of the literature. Chest 1995;108:1748-51.
26. McEniery PT, Dorosti K, Schiavone WA, Pedrick TJ, Sheldon WC. Clinical and angiographic features of coronary artery disease after chest irradiation. Am J Cardiol 1987;60:1020-4.
27. Austin-Seymour M, Munzenrider J, Goitein M, Verhey L, Urie M, Gentry R, et al. Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg 1989;70:13-7.
28. Austin-Seymour M, Munzenrider J, Linggood R, Goitein M, Verhey L, Urie M, et al. Fractionated proton radiation therapy of cranial and intracranial tumors. Am J Clin Oncol 1990;13:327-30.
29. Austin-Seymour M, Urie M, Munzenrider J. Considerations in fractionated proton radiation therapy: clinical potential and results. Radiother Oncol 1990;17:29-35.
30. Suit H, Urie M. Proton beams in radiation therapy. J Natl Cancer Inst 1992;84:155-64.
31. Slater JM, Slater JD, Archambeau JO. Proton therapy for cranial base tumors. J Craniofac Surg 1995;6:24-6.
32. Suit H. Regaud Lecture, Granada 1994. Tumors of the connective and supporting tissues. Radiother Oncol 1994;34:93-104.
33. Zagars GK, Ballo MT. Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2003;56:473-81.
34. Hug EB, Fitzek MM, Liebsch NJ, Munzenrider JE. Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning. Int J Radiat Oncol Biol Phys 1995;31:467-76.
35. Hug EB, Adams J, Fitzek M, De Vries A, Munzenrider JE. Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. Int J Radiat Oncol Biol Phys 2000;47:979-84.
36. Isacsson U, Hagberg H, Johansson KA, Montelius A, Jung B, Glimelius B. Potential advantages of protons over conventional radiation beams for paraspinal tumours. Radiother Oncol 1997;45:63-70.
37. Weber DC, Trofimov AV, Delaney TF, Bortfeld T. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Int J Radiat Oncol Biol Phys 2004;58:1596-606.
38. Miralbell R, Cella L, Weber D, Lomax A. Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams. Int J Radiat Oncol Biol Phys 2000;47:1111-9.
39. Smith AR, Loeffler JS, Adams JA, Lomax AJ, Niemierko A. The potential for proton therapy to improve clinical outcomes: Comparisons of proton and x-ray treatment plans for the purpose of tumor dose escalation and/or reduction of treatment-related morbidity. Int J Radiat Oncol Biol Phys 2000;48(Suppl):338 (abstr 2150).